| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0034 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.004 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |